Testicular Cancer Clinical Trials

31 recruitingLast updated: June 17, 2026

There are 31 actively recruiting testicular cancer clinical trials across 13 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3. Top locations include Groningen, Netherlands, Nashville, Tennessee, United States, Canton, Ohio, United States. Updated daily from ClinicalTrials.gov.


Testicular Cancer Trials at a Glance

31 actively recruiting trials for testicular cancer are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Groningen, Nashville, and Canton. Lead sponsors running testicular cancer studies include University Medical Center Groningen, IRCCS Azienda Ospedaliero-Universitaria di Bologna, and University of Arizona.

Browse testicular cancer trials by phase

Treatments under study

About Testicular Cancer Clinical Trials

Looking for clinical trials for Testicular Cancer? There are currently 29 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Testicular Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Testicular Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Phase 1

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Endometrial CancerTesticular CancerPlatinum Resistant Ovarian Cancer
Context Therapeutics Inc.156 enrolled14 locationsNCT06515613
Recruiting
Phase 1Phase 2

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

Head and Neck CancerThoracic CancerTesticular Cancer+1 more
University of Arizona25 enrolled1 locationNCT07407582
Recruiting

DESTINY-PANTUMOUR04

Liver CancerEsophageal CancerPancreatic Cancer+24 more
AstraZeneca100 enrolled17 locationsNCT07124000
Recruiting
Phase 1Phase 2

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Cervical CancerMelanomaNon-small Cell Lung Cancer+8 more
University of Arizona30 enrolled2 locationsNCT06814496
Recruiting
Phase 1

Brodalumab in the Treatment of Immune-Related Adverse Events

Breast CancerLiver CancerEsophageal Cancer+15 more
Brian Henick, MD11 enrolled1 locationNCT06673329
Recruiting

Integrated Cancer Repository for Cancer Research

Breast CancerLiver CancerEsophageal Cancer+47 more
University of Nebraska999,999 enrolled42 locationsNCT02012699
Recruiting
Not Applicable

Digital Peer Navigation for Adolescents and Young Adults With Cancer

Breast CancerSarcomaLymphoma+1 more
University Health Network, Toronto138 enrolled1 locationNCT06193369
Recruiting
Phase 1

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

Hearing LossMetastatic Malignant Germ Cell TumorMetastatic Malignant Nongerminomatous Germ Cell Tumor+4 more
City of Hope Medical Center44 enrolled1 locationNCT07218913
Recruiting
Not Applicable

Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients

Metastatic Testicular Cancer
Centre Leon Berard236 enrolled12 locationsNCT05588700
Recruiting
Not Applicable

Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer

Quality of LifeTesticular CancerSeminoma+2 more
Sahlgrenska University Hospital160 enrolled1 locationNCT07498959
Recruiting
Phase 3

Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.

Testicular Cancer
Indiana University142 enrolled2 locationsNCT06593665
Recruiting
Not Applicable

Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy

Testicular Cancer
Loma Linda University80 enrolled1 locationNCT06828185
Recruiting
Phase 2

A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy

Germ Cell TumorTesticular Cancer
Wake Forest University Health Sciences35 enrolled3 locationsNCT06866964
Recruiting
Not Applicable

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

Breast CancerColorectal, CancerSarcoma+3 more
Duke University260 enrolled1 locationNCT06371768
Recruiting
Not Applicable

The TASTY-steering Study

Metastatic Triple Negative Breast Cancer or Metastatic Testicular Cancer, or Stage II-IV Diffuse Large B Cell Lymphoma
University Medical Center Groningen201 enrolled11 locationsNCT07258563
Recruiting
Phase 1

A Study of GV20-0251 in Advanced or Refractory Solid Tumors

Endometrial CancerCholangiocarcinomaMelanoma+5 more
West China Hospital10 enrolled1 locationNCT07106827
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Breast CancerOvarian CancerEndometrial Cancer+40 more
Massive Bio, Inc.50,000 enrolled68 locationsNCT03452774
Recruiting
Phase 2

A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases

Testicular Cancer
Western University, Canada30 enrolled1 locationNCT06932458
Recruiting

Voiding and Erectile Function After Retroperitoneal Lymph Node Dissection for Testicular Cancer

Testicular Cancer
Jagiellonian University20 enrolled1 locationNCT06954233
Recruiting

Early Ageing During Therapy in AYA Cancer Patients

Breast CancerCervical CancerCancer+5 more
University Medical Center Groningen120 enrolled1 locationNCT05062707